Vitina Carriero
Overview
Explore the profile of Vitina Carriero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fadda G, Rustichelli C, Soccal S, Moglio S, Serrone A, Bertolini F, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002914
Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma are mutually correlated with Type-2 inflammation. Dupilumab is effective in uncontrolled and relapsing CRSwNP. However, the precise characterization of Type-2 inflammation and...
2.
Levra S, Giannoccaro F, Chernovsky M, Carriero V, Arrigo E, Bertolini F, et al.
J Breath Res
. 2025 Jan;
19(2.
PMID: 39836984
Sarcoidosis is considered a T-helper (Th) 1 related disease, but a transition from Th1 to Th2 pathway activation has been postulated in sarcoidosis-associated pulmonary fibrosis (SAPF). Fraction of exhaled nitric...
3.
Riccardi E, Guida G, Garino S, Bertolini F, Carriero V, Brusamento M, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200892
: Indirect comparison among biologics in severe asthma (SA) is a challenging but desirable goal for clinicians in real life. The aim of the study is to define characteristics of...
4.
Di Stefano A, Gnemmi I, Rosani U, Maniscalco M, DAnna S, Brun P, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542260
Notch signaling is involved in the prevention of cell differentiation and cell fate in various organs, including the lungs. We aimed to determine the transcriptomic and protein expression of Notch...
5.
Levra S, Rosani U, Gnemmi I, Brun P, Leonardi A, Carriero V, et al.
ERJ Open Res
. 2023 Dec;
9(6).
PMID: 38111541
Background: There is increasing evidence of autophagy activation in COPD, but its role is complex and probably regulated through cell type-specific mechanisms. This study aims to investigate the autophagic process...
6.
Di Stefano A, Rosani U, Levra S, Gnemmi I, Brun P, Maniscalco M, et al.
Biology (Basel)
. 2023 Oct;
12(10).
PMID: 37887014
Background: Bone morphogenic proteins (BMPs) and their antagonists are involved in the tissue development and homeostasis of various organs. Objective: To determine transcriptomic and protein expression of BMPs and their...
7.
Guida G, Bertolini F, Carriero V, Levra S, Sprio A, Sciolla M, et al.
J Clin Med
. 2023 Sep;
12(17).
PMID: 37685515
High total IgE levels are weak predictors of T2 and have been reported in nonallergic asthma. Therefore, the role of total serum IgE (IgE) in the T2 phenotype is still...
8.
DAnna S, Dossena F, Gnemmi I, Brun P, Spanevello A, Carriero V, et al.
Respir Med
. 2023 May;
215:107297.
PMID: 37245650
Background: Characterization of COPD patients with rapid lung functional decline is of interest for prognostic and therapeutic reasons. We recently reported an impaired humoral immune response in rapid decliners. Objective:...
9.
Ricciardolo F, Guida G, Bertolini F, Di Stefano A, Carriero V
Eur Respir Rev
. 2023 May;
32(168).
PMID: 37197769
The heterogeneity of asthma makes it challenging to unravel the pathophysiologic mechanisms of the disease. Despite the wealth of research identifying diverse phenotypes, many gaps still remain in our knowledge...
10.
Levra S, Guida G, Sprio A, Crosa F, Ghio P, Bertolini F, et al.
Biomedicines
. 2022 Dec;
10(12).
PMID: 36551989
Pirfenidone and nintedanib are the only two drugs approved for the treatment of idiopathic pulmonary fibrosis (IPF). Both proved to be safe and well-tolerated in clinical trials, but real-world data...